Market Cap 10.27M
Revenue (ttm) 460,000.00
Net Income (ttm) -20.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,486.96%
Debt to Equity Ratio 0.00
Volume 458,364
Avg Vol 16,241,992
Day's Range N/A - N/A
Shares Out 21.57M
Stochastic %K 72%
Beta 2.04
Analysts Strong Buy
Price Target N/A

Company Profile

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone...

Industry: Health Information Services
Sector: Healthcare
Phone: 214 242 9619
Address:
17130 N. Dallas Parkway, Suite 240, Dallas, United States
FredFeuerstein
FredFeuerstein Sep. 18 at 7:43 PM
$MGRX How a bout a happy hour
0 · Reply
J85bcfc
J85bcfc Sep. 18 at 7:38 PM
$MGRX strange action on a Friday. Are we gona see a new colab partner come Monday 🧐
0 · Reply
fivehundredpercent
fivehundredpercent Sep. 18 at 4:44 PM
$MGRX this is looking like its heading to dollars again see chart did it now to long same chart signals going off again
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 18 at 4:28 PM
$MGRX perking here awaiting a new business combo to replace the one that was terminated move to over $1 when it came out
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 16 at 1:33 PM
$MGRX some vol and a decent bidder
0 · Reply
2jmoney
2jmoney Sep. 16 at 12:46 AM
$MGRX back in on the late dump today, TY. 90k at .40. Let the fed give me those 36s I been waiting on for 2 months plz
0 · Reply
Zboquid
Zboquid Sep. 11 at 11:55 PM
$MGRX 💩
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 11 at 4:11 PM
$MGRX added a few more , compliance til Feb 2027, after the failed business combo -Nuclea deal , actively seeking another one. Ran to 1.25 in late July, so probably similar when another combo is announced
0 · Reply
FredFeuerstein
FredFeuerstein Sep. 9 at 7:11 PM
$MGRX Maybe a happy hour today?
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 8 at 7:51 PM
$MGRX took a starter, theyre searching for another business combination to replace the one that was terminated a few weeks ago, has compliance til Feb 2027
1 · Reply
Latest News on MGRX
Mangoceuticals Quarterly report: Q2 2026

Aug 13, 2026, 7:00 AM EDT - 5 weeks ago

Mangoceuticals Quarterly report: Q2 2026


Mangoceuticals Quarterly report: Q1 2026

May 19, 2026, 7:00 AM EDT - 4 months ago

Mangoceuticals Quarterly report: Q1 2026


Mangoceuticals Annual report: Q4 2025

Apr 1, 2026, 7:00 AM EDT - 5 months ago

Mangoceuticals Annual report: Q4 2025


Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today?

2026-03-23T13:27:03.000Z - 6 months ago

Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today?


Mangoceuticals files civil lawsuit against Clarity Ventures

2026-03-17T20:15:36.000Z - 6 months ago

Mangoceuticals files civil lawsuit against Clarity Ventures


Mangoceuticals announces patent filing for MGX-0024

2026-03-06T21:10:53.000Z - 6 months ago

Mangoceuticals announces patent filing for MGX-0024


Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today

2026-02-20T14:09:28.000Z - 7 months ago

Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today


Mangoceuticals Registration statement: Registration Filing

Jan 23, 2026, 7:00 AM EST - 8 months ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals Registration statement: Registration Filing

Jan 13, 2026, 7:00 AM EST - 8 months ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 10 months ago

Mangoceuticals Quarterly report: Q3 2025


Eli Lilly says ‘no affiliation’ with Mangoceuticals

2025-11-13T19:30:24.000Z - 10 months ago

Eli Lilly says ‘no affiliation’ with Mangoceuticals

LLY NVO


Mangoceuticals Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Mangoceuticals Quarterly report: Q2 2025


Mangoceuticals files $150M mixed securities shelf

2025-06-13T20:35:18.000Z - 1 year ago

Mangoceuticals files $150M mixed securities shelf


Mangoceuticals Registration statement: Registration Filing

Jun 13, 2025, 8:00 AM EDT - 1 year ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals Registration statement: Registration Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals shares results from field studies on MGX-0024

2025-05-27T13:15:43.000Z - 1 year ago

Mangoceuticals shares results from field studies on MGX-0024


Mangoceuticals Quarterly report: Q1 2025

May 15, 2025, 12:00 AM EDT - 1 year ago

Mangoceuticals Quarterly report: Q1 2025


Mangoceuticals Annual report: Q4 2024

Mar 19, 2025, 7:00 PM EDT - 1 year ago

Mangoceuticals Annual report: Q4 2024


Mangoceuticals Proxy statement: Proxy Filing

Feb 18, 2025, 7:00 AM EST - 1 year ago

Mangoceuticals Proxy statement: Proxy Filing


Mangoceuticals Proxy statement: Proxy Filing

Feb 6, 2025, 7:00 AM EST - 1 year ago

Mangoceuticals Proxy statement: Proxy Filing


Mangoceuticals Quarterly report: Q3 2024

Nov 14, 2024, 4:00 PM EST - 1 year ago

Mangoceuticals Quarterly report: Q3 2024


Mangoceuticals Registration statement: Registration Filing

Aug 16, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals Quarterly report: Q2 2024

Aug 15, 2024, 7:00 AM EDT - 2 years ago

Mangoceuticals Quarterly report: Q2 2024


Mangoceuticals Earnings release: Q2 2024

Aug 15, 2024, 7:00 AM EDT - 2 years ago

Mangoceuticals Earnings release: Q2 2024


Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 18, 2024, 4:05 PM EDT - 2 years ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access


Mangoceuticals Proxy statement: Proxy Filing

May 16, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Proxy statement: Proxy Filing


Mangoceuticals Quarterly report: Q1 2024

May 15, 2024, 6:00 PM EDT - 2 years ago

Mangoceuticals Quarterly report: Q1 2024


Mangoceuticals Registration statement: Registration Filing

May 6, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals Proxy statement: Proxy Filing

May 6, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Proxy statement: Proxy Filing


Mangoceuticals Registration statement: Registration Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Registration statement: Registration Filing


Mangoceuticals Annual report: Q4 2023

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Annual report: Q4 2023


FredFeuerstein
FredFeuerstein Sep. 18 at 7:43 PM
$MGRX How a bout a happy hour
0 · Reply
J85bcfc
J85bcfc Sep. 18 at 7:38 PM
$MGRX strange action on a Friday. Are we gona see a new colab partner come Monday 🧐
0 · Reply
fivehundredpercent
fivehundredpercent Sep. 18 at 4:44 PM
$MGRX this is looking like its heading to dollars again see chart did it now to long same chart signals going off again
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 18 at 4:28 PM
$MGRX perking here awaiting a new business combo to replace the one that was terminated move to over $1 when it came out
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 16 at 1:33 PM
$MGRX some vol and a decent bidder
0 · Reply
2jmoney
2jmoney Sep. 16 at 12:46 AM
$MGRX back in on the late dump today, TY. 90k at .40. Let the fed give me those 36s I been waiting on for 2 months plz
0 · Reply
Zboquid
Zboquid Sep. 11 at 11:55 PM
$MGRX 💩
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 11 at 4:11 PM
$MGRX added a few more , compliance til Feb 2027, after the failed business combo -Nuclea deal , actively seeking another one. Ran to 1.25 in late July, so probably similar when another combo is announced
0 · Reply
FredFeuerstein
FredFeuerstein Sep. 9 at 7:11 PM
$MGRX Maybe a happy hour today?
0 · Reply
i_like_bb_stock
i_like_bb_stock Sep. 8 at 7:51 PM
$MGRX took a starter, theyre searching for another business combination to replace the one that was terminated a few weeks ago, has compliance til Feb 2027
1 · Reply
FredFeuerstein
FredFeuerstein Sep. 4 at 7:29 PM
$MGRX How about a “Happy Hour” on a Happy Friday
1 · Reply
Zackpedia
Zackpedia Sep. 1 at 11:08 PM
$MGRX Down to .36, you could’ve sold…
0 · Reply
2jmoney
2jmoney Sep. 1 at 2:33 PM
$MGRX give my those .36s it’s been 4 days on the bid 😔
0 · Reply
FredFeuerstein
FredFeuerstein Aug. 28 at 3:22 PM
$MGRX Thats all i need
0 · Reply
FredFeuerstein
FredFeuerstein Aug. 28 at 3:21 PM
$MGRX Is this goong to be a Happy Friday?
0 · Reply
TurtleTeeTradez
TurtleTeeTradez Aug. 27 at 9:40 PM
Check all my past calls 👀🔥 $MGRX: $0.38 → $1.25 on merger news 🚀 $ONFO: $2.20 → $6.00 just 3 days after the R/S 🔥 $TRUG: $0.70 → $2.40 💥 If you missed these and all the previous runners I called, DON’T miss the next one. 👀🔥 $ARTL is setting up BIG. R/S Monday → ~547K FLOAT 🚨 Catalyst inbound → 🚀 Past runner + ultra-tiny float = serious potential. With a float this small, it may not take much volume to trigger a major move. ⚡️ $ARTL is one I’m watching VERY closely. 👀🚀
1 · Reply
divingmonkey28
divingmonkey28 Aug. 27 at 5:26 PM
$MGRX cant even sell bcs of how little volume
0 · Reply
alia127
alia127 Aug. 27 at 4:32 PM
$MGRX a bit of movement. Another spike to 0.8 will be nice 👍
0 · Reply
Bennie123
Bennie123 Aug. 25 at 4:23 PM
$JOB is interesting to me not because staffing suddenly becomes a great AI-era business, but because the **public-company wrapper itself may have value**. JOB has roughly: • ~$20M cash • ~110M shares outstanding • NYSE American listing • manageable balance sheet • active Roth Capital strategic review • management recently saying the process has made **“substantial progress”** Meanwhile AI is creating huge capital needs across nuclear/SMR, data centers, grid/storage, generators, chips, memory, cooling, space infrastructure, etc. We just watched Nuclea try to use $MGRX as a public-market vehicle, only for the deal to fail partly because the required $15M PIPE didn't materialize. So here's the speculative thought: **Why couldn't Nuclea—or another capital-hungry private AI-infrastructure/energy company—look at $JOB and use a similar strategy, except with a partner that already has substantial cash?**
1 · Reply
widar
widar Aug. 25 at 1:59 PM
$MGRX one last death push ?
1 · Reply
rareri
rareri Aug. 24 at 9:26 PM
$MGRX scam!!!
0 · Reply